|
| 26902887 | DNA methylation profiles in African American prostate cancer patients in relation to disease progression. | Genomics | 2019 |
| 30304370 | Pisces: an accurate and versatile variant caller for somatic and germline next-generation sequencing data. | Bioinformatics | 2019 |
| 26902887 | DNA methylation profiles in African American prostate cancer patients in relation to disease progression. | Genomics | 2019 |
| 30304370 | Pisces: an accurate and versatile variant caller for somatic and germline next-generation sequencing data. | Bioinformatics | 2019 |
| 29635542 | Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification. | Ann Oncol | 2018 |
| 29635542 | Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification. | Ann Oncol | 2018 |
| 27358489 | Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer. | Clin Cancer Res | 2017 |
| 28496006 | Gene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort. | Oncotarget | 2017 |
| 29137428 | <i>PTEN</i> loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles. | Oncotarget | 2017 |
| 27358489 | Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer. | Clin Cancer Res | 2017 |
| 28145099 | Gene expression panel predicts metastatic-lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancer. | Mol Oncol | 2017 |
| 28496006 | Gene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort. | Oncotarget | 2017 |
| 28145099 | Gene expression panel predicts metastatic-lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancer. | Mol Oncol | 2017 |
| 29137428 | <i>PTEN</i> loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles. | Oncotarget | 2017 |
| 27142338 | Prostate tumor DNA methylation is associated with cigarette smoking and adverse prostate cancer outcomes. | Cancer | 2016 |
| 27142338 | Prostate tumor DNA methylation is associated with cigarette smoking and adverse prostate cancer outcomes. | Cancer | 2016 |
| 26612861 | Substantial DNA methylation differences between two major neuronal subtypes in human brain. | Nucleic Acids Res | 2016 |
| 27651837 | Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy. | Clin Epigenetics | 2016 |
| 26612861 | Substantial DNA methylation differences between two major neuronal subtypes in human brain. | Nucleic Acids Res | 2016 |
| 27651837 | Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy. | Clin Epigenetics | 2016 |
| 25916844 | TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer. | Nucleic Acids Res | 2015 |
| 25916844 | TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer. | Nucleic Acids Res | 2015 |
| 26305677 | Targeted or whole genome sequencing of formalin fixed tissue samples: potential applications in cancer genomics. | Oncotarget | 2015 |
| 26383847 | Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue. | Prostate | 2015 |
| 26067621 | DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights. | Epigenomics | 2015 |
| 26692910 | Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors. | Clin Epigenetics | 2015 |
| 26305677 | Targeted or whole genome sequencing of formalin fixed tissue samples: potential applications in cancer genomics. | Oncotarget | 2015 |
| 26383847 | Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue. | Prostate | 2015 |
| 26692910 | Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors. | Clin Epigenetics | 2015 |
| 26067621 | DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights. | Epigenomics | 2015 |
| 24057217 | Differences in DNA methylation between human neuronal and glial cells are concentrated in enhancers and non-CpG sites. | Nucleic Acids Res | 2014 |
| 24057217 | Differences in DNA methylation between human neuronal and glial cells are concentrated in enhancers and non-CpG sites. | Nucleic Acids Res | 2014 |
| 24504028 | Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status. | Sci Rep | 2014 |
| 24728075 | Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancer. | Cancer Res | 2014 |
| 24718283 | Validation study of genes with hypermethylated promoter regions associated with prostate cancer recurrence. | Cancer Epidemiol Biomarkers Prev | 2014 |
| 25179373 | Application of a low cost array-based technique - TAB-Array - for quantifying and mapping both 5mC and 5hmC at single base resolution in human pluripotent stem cells. | Genomics | 2014 |
| 25179373 | Application of a low cost array-based technique - TAB-Array - for quantifying and mapping both 5mC and 5hmC at single base resolution in human pluripotent stem cells. | Genomics | 2014 |
| 24504028 | Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status. | Sci Rep | 2014 |
| 24718283 | Validation study of genes with hypermethylated promoter regions associated with prostate cancer recurrence. | Cancer Epidemiol Biomarkers Prev | 2014 |
| 24728075 | Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancer. | Cancer Res | 2014 |
| 23177740 | Genome-wide methylation profiles reveal quantitative views of human aging rates. | Mol Cell | 2013 |
| 24154874 | APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma. | Cancer Res | 2013 |
| 23177740 | Genome-wide methylation profiles reveal quantitative views of human aging rates. | Mol Cell | 2013 |
| 23550148 | Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. | Cancer Discov | 2013 |
| 23509297 | Whole-genome haplotyping by dilution, amplification, and sequencing. | Proc Natl Acad Sci U S A | 2013 |
| 23571109 | Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel. | Hum Mol Genet | 2013 |
| 24511466 | A panel of CpG methylation sites distinguishes human embryonic stem cells and induced pluripotent stem cells. | Stem Cell Reports | 2013 |
| 24511466 | A panel of CpG methylation sites distinguishes human embryonic stem cells and induced pluripotent stem cells. | Stem Cell Reports | 2013 |
| 24154874 | APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma. | Cancer Res | 2013 |
| 23509297 | Whole-genome haplotyping by dilution, amplification, and sequencing. | Proc Natl Acad Sci U S A | 2013 |